NDUFS3 Human

Histidine NADH Dehydrogenase Fe-S Protein 3 Human Recombinant
Cat. No.
BT13335
Source
Escherichia Coli.
Synonyms
CI-30, NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondria, Complex I-30kD, CI-30kD, NADH-ubiquinone oxidoreductase 30 kDa subunit.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 85.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant Human NDUFS3 produced in E.Coli is a single, non-glycosylated polypeptide chain containing 249amino acids (37-264 a.a.) and having a molecular mass of 28.7 kDa. NDUFS3 is fused to a 21 amino acid His Tag at N-terminus and purified by conventional chromatography techniques.

Product Specs

Introduction
NADH dehydrogenase [ubiquinone] iron-sulfur protein 3 (NDUFS3) is a member of the complex I 30 kDa subunit family. It is one of the iron-sulfur protein (IP) components of mitochondrial NADH:ubiquinone oxidoreductase (complex I), the first enzyme complex in the electron transport chain of mitochondria. The IP fraction of complex I consists of seven subunits. Mutations in the NDUFS3 gene are associated with Leigh syndrome, a condition caused by mitochondrial complex deficiency.
Description
Recombinant Human NDUFS3, expressed in E. coli, is a single, non-glycosylated polypeptide chain comprising 249 amino acids (residues 37-264) with a molecular weight of 28.7 kDa. A 21 amino acid His-tag is fused to the N-terminus of NDUFS3. The protein is purified using standard chromatographic techniques.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The NDUFS3 protein solution (0.25 mg/ml) is supplied in 20mM Tris-HCl buffer (pH 8.0), 0.15M NaCl, 10% glycerol, and 1mM DTT.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended periods, store frozen at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 85.0% as determined by SDS-PAGE analysis.
Synonyms
CI-30, NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondria, Complex I-30kD, CI-30kD, NADH-ubiquinone oxidoreductase 30 kDa subunit.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MESAGADTRP TVRPRNDVAH KQLSAFGEYV AEILPKYVQQ VQVSCFNELE VCIHPDGVIP VLTFLRDHTN AQFKSLVDLT AVDVPTRQNR FEIVYNLLSL RFNSRIRVKT YTDELTPIES AVSVFKAANW YEREIWDMFG VFFANHPDLR RILTDYGFEG HPFRKDFPLS GYVELRYDDE VKRVVAEPVE LAQEFRKFDL NSPWEAFPVY RQPPESLKLE AGDKKPDAK

Product Science Overview

Structure and Function

NDUFS3 is a subunit of the NADH:ubiquinone oxidoreductase complex (Complex I) in the mitochondria. It is involved in the transfer of electrons from NADH to ubiquinone, a key step in the mitochondrial electron transport chain. This process is vital for the generation of a proton gradient across the mitochondrial membrane, which drives ATP synthesis through oxidative phosphorylation.

The recombinant form of this protein is produced in E. coli and is typically non-glycosylated. It is a single polypeptide chain that contains histidine residues, which facilitate its purification and study in laboratory settings .

Importance in Research

The study of NDUFS3 is essential for understanding mitochondrial function and its role in various diseases. Mutations or deficiencies in this protein can lead to mitochondrial dysfunction, which is associated with a range of disorders, including neurodegenerative diseases, metabolic syndromes, and aging-related conditions.

Recombinant NDUFS3 is widely used in research to investigate the mechanisms of mitochondrial diseases and to develop potential therapeutic interventions. By studying the recombinant form, scientists can gain insights into the protein’s structure, function, and interactions with other components of the electron transport chain.

Applications
  1. Disease Research: Understanding the role of NDUFS3 in mitochondrial diseases.
  2. Drug Development: Screening potential drugs that target mitochondrial dysfunction.
  3. Biochemical Studies: Investigating the electron transport chain and ATP synthesis.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.